Synta Pharmaceuticals Corp (NASDAQ:SNTA)

2.21
Delayed Data
As of Jul 06
 +0.03 / +1.38%
Today’s Change
1.85
Today|||52-Week Range
4.97
-16.60%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
AssetsCash96.8M68.5M45.0M33.3M
 
 
 
 
 
Short Term Investment Cash44.8M-28.3M-22.5M-12.8M
 
 
 
 
 
Cash & Short Term Investments112.1M119.3M97.7M76.6M
 
 
 
 
 
 
ReceivablesReceivables0.000.00--0.00--
 
InventoriesInventories----------
 
Current AssetsOther Current Assets2.3M2.9M1.7M1.4M
 
 
 
 
 
Current Assets114.3M122.2M99.3M78.0M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross21.9M21.4M21.5M21.5M
 
 
 
 
 
Depreciation-20.6M-20.3M-20.5M-20.7M
 
 
 
 
 
Other Assets358.0K331.0K305.0K564.0K
 
 
 
 
 
Total Assets115.9M123.7M100.7M79.4M
 
 
 
 
 
 
LiabilitiesAccounts Payable5.2M4.4M3.1M0.00
 
 
 
 
Short Term Debt9.2M9.2M9.3M9.3M
 
 
 
 
 
Accrued Expenses15.5M16.5M14.6M15.3M
 
 
 
 
 
Other Current Liabilities15.5M16.5M14.6M19.1M
 
 
 
 
 
Other Liabilities32.7M33.0M30.9M30.9M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt9.3M7.0M4.7M2.3M
 
 
 
 
 
Total Liabilities41.9M39.9M35.5M33.3M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity74.0M83.7M65.1M46.1M
 
 
 
 
 
Total Shareholder Equity74.0M83.7M65.1M46.1M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding101.3M108.9M109.1M109.1M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.
 

To view my watchlist

Not a member yet?

Sign up now for a free account